7.76
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MoonLake Immunotherapeutics | MLTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 7.76 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.76 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 4.25 - 15.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 7.76 | USD |
Period:
Draw Mode:
MoonLake Immunotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 286.54M | 36.93M | 10.62M | $ - | $ - | -1.45 | -3.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 4.10% |
MoonLake Immunotherapeut... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MLTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.18 | 8.25 | 6.9305 | 7.55 | 7,282 | 0.58 | 8.08% |
| 1 Month | 8.32 | 8.60 | 6.9305 | 7.47 | 19,434 | -0.56 | -6.73% |
| 3 Months | 5.92 | 10.27 | 5.13 | 7.27 | 53,425 | 1.84 | 31.08% |
| 6 Months | 12.37 | 15.00 | 4.25 | 6.88 | 97,498 | -4.61 | -37.27% |
| 1 Year | 12.37 | 15.00 | 4.25 | 6.88 | 97,498 | -4.61 | -37.27% |
| 3 Years | 12.37 | 15.00 | 4.25 | 6.88 | 97,498 | -4.61 | -37.27% |
| 5 Years | 12.37 | 15.00 | 4.25 | 6.88 | 97,498 | -4.61 | -37.27% |
MoonLake Immunotherapeut... Description
| MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. |